The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...

Let's discuss these factors in detail to understand if GSK’s stock is worth buying now. GSK has more than 20 marketed ...

Shares of GSK PLC GSK inched down 0.34% to £16.04 Wednesday, on what proved to be an all-around rough trading session for the ...

GlaxoSmithKline (GSK) stock climbed on Thursday after the healthcare company announced that CEO Andrew Witty would retire in March 2017. GlaxoSmithKline (GSK) stock climbed on Thursday after the ...

Additionally, I believe GSK's stock will continue to rally thanks to progress made in developing its pipeline of experimental drugs and vaccines, including the FDA's approval of Jemperli in ...

The drug showed similar remission rates to GSK's Nucala. Vandana Singh GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older ...